Article Listing - Pfizer showcases cancer innovations at ASCO 2005; highlights of new data

CHOLINE KEY TO ALZHEIMER'S?

9 March 1992

New research has indicated that a deficiency of the acetylcholine precursor choline may be a prime factor in the etiology...

CORTICOSTEROIDS AND OPTIC NEURITIS

9 March 1992

Optic neuritis, an acute demyelinating disease of the optic nerve which often occurs in multiple sclerosis patients, can be successfully...

ANTI-LEPTOSPIRA MAbs FROM BRAZIL

9 March 1992

Researchers at the Oswaldo Cruz Foundation in Rio de Janeiro, Brazil, claim to have produced monoclonal antibodies specific for blood-borne...

ROCHE CENTER ESTABLISHED IN USA

9 March 1992

A new study center for nervous system injuries at Washington University in St Louis, Missouri, is being set up to...

ROCHE TO PROMOTE GENENTECH'S DNase

9 March 1992

Swiss major Hoffmann-La Roche and Californian biotechnology concern Genentech last week announced four different international R&D agreements using their combined...

WARNING LETTER TO MILES ON NIMOTOP

9 March 1992

Promotion of the neurone-specific calcium channel blocker Nimotop (nimodipine) in the USA by Miles Laboratories for the unapproved indication of...

ORPHAN DRUG BILL FACES VETO

9 March 1992

Sponsors of legislation now in the Senate which would reduce the market monopoly enjoyed by orphan drug makers fear that...

MEDEVA'S NEW CORACTEN FORM

9 March 1992

Medeva plc and its subsidiary Evans Medical have launched in the UK a new product in the Coracten (nifedipine) range....

HUMAN CARCINOMA ANTIGEN

9 March 1992

Massachusetts-based company Epigen Inc has signed an agreement with investigators at the University of Oslo, Norway, to characterize the HC...

BIOCHEM PHARMA'S JOHN GILLARD

9 March 1992

John Gillard has been appointed as director of therapeutic research at BioChem Pharma Inc of Canada. 1614869 COST CONTAINMENT MEASURES...

Showing 94711-94720 of 95316 articles